InVision Aktiengesellschaft develops and markets products and services in the field of workforce management and education in Europe and the United States.
Excellent balance sheet with concerning outlook.
Share Price & News
How has InVision's share price performed over time and what events caused price changes?
Latest Share Price and Events
7 Day Return
1 Year Return
Return vs Industry: IVX underperformed the German Software industry which returned 19.5% over the past year.
Return vs Market: IVX exceeded the German Market which returned 3.7% over the past year.
Price Volatility Vs. Market
How volatile is InVision's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StCould InVision Aktiengesellschaft's (ETR:IVX) Investor Composition Influence The Stock Price?
1 month ago | Simply Wall StThe InVision (ETR:IVX) Share Price Is Down 65% So Some Shareholders Are Wishing They Sold
2 months ago | Simply Wall StDoes InVision Aktiengesellschaft's (ETR:IVX) CEO Salary Reflect Performance?
Is InVision undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Undervalued: IVX (€19) is trading above our estimate of fair value (€0.86)
Significantly Undervalued: IVX is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: IVX is unprofitable, so we can't compare its PE Ratio to the Software industry average.
PE vs Market: IVX is unprofitable, so we can't compare its PE Ratio to the German market.
Price to Earnings Growth Ratio
Low PEG Ratio: Insufficient data to calculate IVX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: IVX is overvalued based on its PB Ratio (4.9x) compared to the DE Software industry average (3x).
How is InVision forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IVX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IVX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IVX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IVX's revenue (5.5% per year) is forecast to grow faster than the German market (5% per year).
High Growth Revenue: IVX's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: IVX's Return on Equity is forecast to be low in 3 years time (6.9%).
How has InVision performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: IVX is unprofitable, and losses have increased over the past 5 years at a rate of -46.9% per year.
Accelerating Growth: Unable to compare IVX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IVX is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (14.5%).
Return on Equity
High ROE: IVX has a negative Return on Equity (-0.14%), as it is currently unprofitable.
Return on Assets
ROA vs Industry: IVX is currently unprofitable, so its Return on Assets is negative.
Return on Capital Employed
ROCE Improving: IVX is currently unprofitable, so its Return on Capital Employed is negative.
How is InVision's financial position?
Financial Position Analysis
Short Term Liabilities: IVX's short term assets (€5.4M) exceeds its short term liabilities (€3.7M)
Long Term Liabilities: IVX's short term assets (5.4M) exceeds its long term liabilities (2.4M)
Debt to Equity History and Analysis
Debt Level: IVX's debt to equity ratio (1.7%) is considered satisfactory
Reducing Debt: IVX's debt to equity ratio has reduced from 66% to 1.7% over the past 5 years.
Debt Coverage: IVX's debt is well covered by operating cash flow (699%).
Interest Coverage: IVX is unprofitable, therefore interest payments are not well covered by earnings.
Inventory Level: IVX has a high level of physical assets or inventory.
Debt Coverage by Assets: IVX's debt is covered by short term assets (assets are 30.704900x debt).
What is InVision's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate IVX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate IVX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if IVX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IVX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: IVX is not paying a notable dividend for the German market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IVX's dividend in 3 years as they are not forecast to pay a notable one for the German market.
What is the CEO of InVision's salary, the management and board of directors tenure and is there insider trading?
Peter Bollenbeck (46yo)
Mr. Peter Bollenbeck co-founded InVision AG in 1995 and serves as its Chairman of the Executive Board and Chief Executive Officer. Mr. Bollenbeck is responsible for strategy, sales, professional services a ...
CEO Compensation Analysis
Compensation vs. Market: Peter's total compensation ($USD405.50K) is above average for companies of similar size in the German market ($USD216.74K).
Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Peter Bollenbeck (46yo)
Chairman of Executive Board & CEO
- Tenure: 0yrs
- Compensation: €364.02k
Armand Zohari (52yo)
Co-Founder & Member of Executive Board
- Tenure: 0yrs
- Compensation: €66.09k
Matthias Schroer (52yo)
Deputy Chairman of the Supervisory Board
- Tenure: 6.2yrs
- Compensation: €18.75k
Chairman of the Supervisory Board
- Tenure: 0yrs
- Compensation: €25.00k
Member of the Supervisory Board
- Tenure: 0yrs
- Compensation: €12.50k
InVision Aktiengesellschaft's company bio, employee growth, exchange listings and data sources
- Name: InVision Aktiengesellschaft
- Ticker: IVX
- Exchange: XTRA
- Founded: 1995
- Industry: Application Software
- Sector: Software
- Market Cap: €42.465m
- Shares outstanding: 2.24m
- Website: https://www.ivx.com
Number of Employees
- InVision Aktiengesellschaft
- Speditionstraße 5
- North Rhine-Westphalia
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|IVX||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jun 2007|
|IVX||XTRA (XETRA Trading Platform)||Yes||Ordinary Shares||DE||EUR||Jun 2007|
|0EWO||LSE (London Stock Exchange)||Yes||Ordinary Shares||GB||EUR||Jun 2007|
|IVXd||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Ordinary Shares||GB||EUR||Jun 2007|
InVision Aktiengesellschaft develops and markets products and services in the field of workforce management and education in Europe and the United States. Its products include injixo, a workforce managemen ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2019/10/18 21:11|
|End of Day Share Price||2019/10/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.